TG01 vaccine
- Generic Name
- TG01 vaccine
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT05638698
- Locations
- 🇺🇸
University of Kansas Cancer Center - Clinical Research Center, Fairway, Kansas, United States
🇺🇸University of Kansas Cancer Center - Overland Park, Overland Park, Kansas, United States
🇺🇸University of Kansas Cancer Center - Westwood, Westwood, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath